Filtered By:
Cancer: Prostate Cancer
This page shows you your search results in order of date.
Order by Relevance | Date
Total 49 results found since Jan 2013.
The Use of Androgen Deprivation Therapy for Prostate Cancer Lead to Similar Rate of Following Open Angle Glaucoma: A Population-Based Cohort Study
In conclusion, the use of ADT will lead to a similar or lower rate of OAG development.PMID:37296878 | DOI:10.3390/cancers15112915
Source: Cancer Control - June 10, 2023 Category: Cancer & Oncology Authors: Po-Jen Yang Chiao-Wen Lin Chia-Yi Lee Jing-Yang Huang Ming-Ju Hsieh Shun-Fa Yang Source Type: research
Cancers, Vol. 15, Pages 2915: The Use of Androgen Deprivation Therapy for Prostate Cancer Lead to Similar Rate of Following Open Angle Glaucoma: A Population-Based Cohort Study
In conclusion, the use of ADT will lead to a similar or lower rate of OAG development.
Source: Cancers - May 26, 2023 Category: Cancer & Oncology Authors: Po-Jen Yang Chiao-Wen Lin Chia-Yi Lee Jing-Yang Huang Ming-Ju Hsieh Shun-Fa Yang Tags: Article Source Type: research
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
This study evaluates an investigational combination regimen of IMBRUVICA® (ibrutinib) plus venetoclax (I+V) for newly diagnosed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), (Abstracts #7535 and #P617, respectively).Advancing the Science of Solid Tumors Through Precision MedicineJanssen’s continued innovation in solid tumors focuses on advancing precision medicine options for patients with biomarker-driven disease who have limited targeted treatment options and moving patients into earlier lines of therapy when treatments may be more effective. Lung CancerAn oral presentation will report ...
Source: Johnson and Johnson - May 18, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
Synthesis, Biological Activity Evaluation and Molecular Docking of imidazole derivatives possessing hydrazone moiety
Chem Biodivers. 2023 May 2:e202200886. doi: 10.1002/cbdv.202200886. Online ahead of print.ABSTRACTIn an attempt to identify potential active anticancer agents with low cytotoxic properties and CA inhibitors, a new series of hybrid compounds incorporating imidazole ring and hydrazone moiety as part of their structure were synthesized by aza-Michael addition reaction followed by intramolecular cyclization. The structure of synthesized compounds was elucidated using various spectral techniques. Synthesized compounds were evaluated for their in vitro anticancer (prostate cell line; PC3) and CA inhibitory (hCA I and hCA II) act...
Source: Chemistry and Biodiversity - May 3, 2023 Category: Biochemistry Authors: H üseyin Kekeçmuhammed Michael Tapera Ekrem Aydogdu Emin Saripinar Elanur Aydin Karatas Eda Mehtap Uc Mesut Akyuz Burak T üzün İlhami Gulcin R ıfat Emin Bora İlhan Özer İlhan Source Type: research
Relationship between Androgen Deprivation Therapy and Normal-Tension Glaucoma in Patients with Prostate Cancer: A Nationwide Cohort Study
CONCLUSION: Medical castrations for patients with prostate cancer results in a lower incidence of newly diagnosed NTG compared to no ADT. These findings suggest that testosterone may be involved in the pathogenesis of NTG.PMID:36168243 | PMC:PMC9520039 | DOI:10.3349/ymj.2022.0122
Source: Yonsei Medical Journal - September 28, 2022 Category: Universities & Medical Training Authors: Jee Soo Ha Hye Sun Lee Ju-Young Park Jinhyung Jeon Do Kyung Kim Min Kim Ho Sik Hwang Tae Hyo Kim Hyun Kyu Ahn Kang Su Cho Source Type: research
